Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way?

Could Bristol Myers Squibb and Johnson & Johnson Have a Powerful New Blood Thinner on the Way?

Source: 
Motley Fool
snippet: 
  • BMS and J&J recently reported positive results from a phase 2 study of an experimental blood thinner.
  • This candidate could potentially compete against the two companies' current blockbuster blood thinners.
  • BMS and J&J expect to report data from a phase 2 study in stroke in the first half of 2022.